Key Words: drug labeling; medication errors; drug compounding

Introduction

In health institutions, safe and quality care has become in recent years a growing concern and it is currently a global priority [1]. Interventions conducted by health professionals, to benefit patients, can cause damage or adverse events [2]; one of the principal adverse events is medication error, [3],[4] defined as “any preventable incident that can cause damage to patients or lead to an inappropriate use of medications when these are under control of health professionals” [5]. The World Health Organization, in the document World Alliance for Patient Safety 2008, states that in acute patient services, between 7% and 10% have presented some event related to incorrect medication administration. At the same time, it indicates that these are preventable within a range between 28% and 56% and that developing countries have higher rates of these events related to medication administration errors [6].

The etiology of medication errors can take place in any stage of the process: prescription, transcription, dispensing, preparation, and administration [6],[7],[8],[9]. The stages most vulnerable to error are prescription and administration, which are responsible for 50% or more errors during the whole process [5],[8],[10],[11], and [12]. In Chile, evidence is still not available that permits dimensioning the magnitude of the complete problem: however, it is known that these errors occur and contribute to the mortality of hospitalized patients [6].

In the institution where this study took place, the hospitalization units are staffed with one professional for every eight patients, and the intensive care unit is staffed with one or two professionals per patient according to severity. Said institution uses a barcode system for medication dispensing and administration, with the nurse or matron, according to the unit, who administers the medications to the patient.

Given that during the first year of the institution’s operation, errors occurred in medication administration, by using the traditional labelling system, we sought the best evidence available on the most efficient measures to prevent these errors, finding vast evidence that predesigned labelling is an effective strategy to prevent medication errors [12],[13],[14],[15]. This is why it was decided to implement this type of labelling for administration of medication and intravenous fluids, through administration access routes and infusion pumps, as strategy to prevent errors.

After this implementation, the result of this change was assessed through the following question: In patients with invasive access routes and lines from hospitalized units, emergency, recovery ward, does predesigned labelling system for medication administration diminish the risk of medication errors compared to traditional labelling?

Objectives of the study:

1. To assess the effectiveness of predesigned labelling in medication administration through lines and invasive lines to prevent medication errors with hospitalized patients, in emergency, and recovery ward.
2. To characterize medication errors in hospitalized patients, in emergency, surgical, and recovery ward.

Methods

A pre- and post-intervention study was carried out in a private clinic in Santiago de Chile, studying the dosages of drugs administered through invasive lines to hospitalized patients, patients in emergency, surgical ward and recovery. Patients were considered hospitalized if interned in any of the following units: pediatrics, critical pediatric patient unit (CPPU), medical-surgical, mental health, critical adult patient unit (CAPU), gynecology and maternity, and neonatology.

Hypothesis
The predesigned labelling system for medication administration through invasive access routes and lines of patients is a better measure to prevent medication errors than the traditional labelling system.

Sample selection and size
The sample was intentioned, non-probabilistic. The pre-intervention group used the habitual, not predesigned labelling, which was made up of 5,819 doses of drugs administered through invasive lines to patients from the services described from 01 June 2014 to 31 December 2014. The post-intervention group, which used the predesigned labelling, was made up of 8,585 doses of drugs administered through invasive lines to patients from the same services between 01 January and 30 June 2015.

Inclusion and exclusion criteria

The study included dosages administered through endo-venous, subcutaneous, intramuscular, peridural, and brachial plexus access to patients from the units described. The study excluded dosages of drugs administered through other routes, like oral, sublingual, topical, inhaled, vaginal, and rectal.

Measurement of variables

Dependent variable or primary result. Medication error was considered the primary result. It was defined as any error occurring during the medication administration process, only during the preparation and administration stages, whether the error bears an adverse consequence or not [16],[17]. Data collection of medication errors was performed in reference to the notification of adverse events and of the monitoring forms of the event by the quality unit.

Secondary results. The error characteristics were considered secondary results. These were type of error, service of occurrence, number of medications administered simultaneously when error occurred, name of medications administered, day of the week of occurrence, administration during day or night shift, form of administration (bolus, continuous), administration route (peripheral venous access, central venous route, subcutaneous, intramuscular, peridural, brachial plexus), type of medication administered (categorized into vasoactive drug, sedation, analgesia, antibiotic, hydration, others) and severity of the error defined according to the National Coordinating Council for Medication Error Reporting and Prevention, 2005 [5]. The National Coordinating Council for Medication Error Reporting and Prevention scale has a score from 1 to 9, with:

1 = A (circumstances or incidents with capacity to cause error).

2 = B (the error occurred, but did not reach the patient).

3 = C (error reached the patient, but without damage).

4 = D (the error reached the patient, did not cause damage but needed monitoring).

5 = E (error caused temporary damage and needed treatment or intervention).

6 = F (error caused temporary damage and needed hospitalization or its prolongation).

7 = G (error caused permanent damage to the patient).

8 = H (error compromised the patient’s life).

9 = I (error caused the patient’s death).

All the prior information was obtained from the patient’s electronic file.

Independent variable. Type of labelling.

Traditional labelling: consisted of a white adhesive paper, hand written by the health professional who administered the medication and which was adhered to the medication container. This label had no pre-established data and had to be labeled with name of the patient, medication, dilution, dosage, person responsible for the administration, and date and hour of preparation. Traditional labelling of invasive lines consisted of a white paper hand written by the health professional who administered the medication, which was adhered to the invasive line. This label should register date and type of line (arterial, venous and peripheral, central).

Predesigned labelling: comprised of five types of adhesive labels, with pre-established data filled out manually by the professional administering the medication. The five types are the following:

1. Label for the administration of solutions: label with white background and black letters, with the following pre-established data: date, name of patient, room, solution, total volume, drug, dosage, hour started, and person responsible for the administration.
2. Label of bolus medication: label with white background and black letters, with the following pre-established data: date, name of patient, room, drug, dilution, solution, hour started, and person responsible for the administration.
3. Label of medication in infusion pump: adhesive label with white background and black letters, with the following pre-established data: date, name of patient, room, drug, dosage, solution, total volume, hour started, and person responsible for the administration.
4. Label of grouping of drugs according to color: adhesive colored labels grouped by types of medications (Figure 1).

Labelling of invasive access lines: adhesive colored labels with pre-established data (Figure 2), which were adhered to the invasive access lines whenever corresponding (Figure 2). 

Figure 1. Labels of drug grouping according to color.

Figure 2. Predesigned labels for invasive lines.

Prior to starting the application of the intervention, the researchers socialized the changes in all the study units. Thereafter, the nurses and matrons, who administer the medications, were trained on the implementation of the new measures for one month. The researchers designed a checklist to monitor compliance of the new intervention, which was evaluated through a pilot test. With this checklist, the researchers supervised, periodically and randomly, compliance with the predesigned labelling in the different units throughout the study period.

Statistical analysis
Statistical analysis was performed with Stata 10 computational system. Summary measurements were used for descriptive analysis. The relative risk (RR) was calculated with 95% confidence interval and absolute risk reduction (ARR). A hypothesis test was conducted for comparing two proportions with α = 0.05.

Ethical considerations
The Clinic’s General Board of Directors approved the study. This board issued a document that states no approval was requested from the Ethics Committee because the work entails an assessment of a strategy for continuous improvement in patient care. This document was delivered to the journal editors. Within the evidence-based practice model used in the clinic, the assessment of the implementation of evidence is the last stage.

Results

During the evaluation period, 14,404 doses of medication were administered to 1,722 patients through invasive route. The pre-intervention group (traditional medication labelling) was comprised of 5,819 dosages administered to 634 patients, and the post-intervention group (predesigned medication labelling) of 8,585 doses administered to 1,088 patients.

The rate of incidence of errors in medication administration during the study period was 0.83 x 1000 doses administered. Of all the errors (12) occurring during el study, 66.6% took place in the adult intensive care unit and 16.6% in the pediatric and medical-surgical units, respectively (p = 0.018). It was noted that 33% occurred during holidays, 58.3% during the day shift, 41.6% in the mornings, and 41.6% at night; 41.6% occurred on Mondays. The average number of medications administered simultaneously, when the error occurs, was three with a range from 1 to 5; 33.3% of the errors corresponded to vasoactive drugs and the same proportion corresponded to sedatives. The most frequent type of error was the administration of incorrect dosage (66.6%), followed by administration of wrong medication and wrong hour for administration. One-hundred percent of the medications was administered via endo-venous route, with 58.3% through central venous access and 41.7% through peripheral venous access; 83.3% was administered in continuous infusion (Table 1).

Table 1. Characteristics of medication administration errors according to type of labelling in the study groups.

The medication administration error rate in the pre-intervention group was 1.5 x 1000 administrations, and in the post-intervention group it was 0.3 x 1000 (p = 0.018). Relative risk was 4.6 (95% CI: 1.25 to 25.42), reduction of error rates was by 80%. Absolute risk reduction was 11.97 (95% CI: 1.12 to 22.82). Some errors (41.2%) produced some type of damage to patients and 58.8% had no consequences in patients; three errors caused temporary damage and needed intervention, and two events compromised the patient’s life. The most severe damages occurred in the group without predesigned labelling.

Discussion

This study was conducted in a clinic, which has the mission and vision of being an institution with high quality standards for which it has several conditions that favor the patient’s safety, like the nurse/patient staffing, use of a barcode system for dispensing and medication administration and the medication administration conducted only by professionals. These conditions could have contributed to a lower rate of medication errors compared to other studies [6],[10],[18],[19], given that, for example, using a barcode system for dispensing and medication administration diminishes the probability of medication error according to several authors [16],[18],[20],[21],[22],[23].

Furthermore, this work focused on studying the medication errors occurring only during the last two phases of the medication administration process, that of preparation and administration, given that the literature reveals that these are the stages with the highest frequency of medication errors [6],[9],[10],[11],[12],[24],[25], which also could have reflected a lower error rate compared to other studies.

The characteristics of the errors are similar to those of other studies, occurring more frequently in the intensive care unit [6], in the morning [8], and administered by intravenous route [9],[25]. The most frequent error was the incorrect dosage [6],[16],[20],[26],[27]. An important number of patients who received an erroneously administered medication suffered some damage, which was reversed with different interventions from the health staff according to the case. The majority of these cases were patients from the critical adult patient unit.

Estimates show that the highest frequency of medication errors occurs in critical patient units [7]. These units use a higher number of medications in patients [6], [28] and patients receive more simultaneous administrations of medications than in other units.

The results are divergent from other authors regarding the type of drugs administered when the error occurs [6],[10]. This would be explained because the populations from other studies are different, that is, for example, only pediatric or only from the critical patient unit; or from special units, like transplants, where the medications to be administered vary according to the types of patients. 

Predesigned labelling diminished significantly medication errors in the study population (80%), which shows that it is an important prevention measure. This agrees with other studies that show better efficiency when using colored labelling in intensive care units and emergencies [12],[13], and where colored labels facilitate identifying the correct access of invasive lines [13],[14],[15].

Limitations of the study

The way of measuring errors through notification and not through direct observation may have influenced on the under-reporting of errors.

The type of sampling through convenience affects the study’s external validity.

Conclusion

The effectiveness of predesigned labelling to prevent medication errors was assessed positively during the last two stages of the medication administration process. Error rates were reduced by 80%, which is a reason to recommend the implementation of policies for labelling use, as a quality norm in patient care.

Thus, predesigned labelling represents a support for the health staff, as well as a contribution to other institutions with a holistic vision aimed at maintaining and consolidating the rights of hospitalized patients.

Notes

From the editor
The authors originally submitted this article in Spanish and subsequently translated it into English. The Journal has not copyedited this version.

Ethical aspects
The Journal is aware that the Medical Board at Clínica Universidad de Los Andes, Chile, knew about this study and of its possible publication in a journal of biomedical dissemination.

Declaration of conflict of interest
The authors completed the ICMJE’s conflict of interest declaration form, and declare not having received funding to conduct the report; not having financial relations with organizations that could have interests in the published article, in the last three years; and not having other relationships or activities that could influence upon the article published. The forms may be requested by contacting the corresponding author or the journal’s editorial board.

Funding
The authors declare having no external funding sources.

Note from the editor
The principal or responsible author states that this manuscript is an honest, precise, and transparent transcription of the study reported; that no important aspect from the study has been omitted; and that discrepancies between the study results and those foreseen (if these were relevant) have been registered and explained.

Figure 1. Labels of drug grouping according to color.

Figure 2. Predesigned labels for invasive lines.

Table 1. Characteristics of medication administration errors according to type of labelling in the study groups.

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.